Effect of Chronic Exenatide Therapy on Beta Cell Function and Insulin Sensitivity in Type 2 Diabetes Mellitus (T2DM)
Latest Information Update: 24 Jul 2023
At a glance
- Drugs Dapagliflozin (Primary) ; Exenatide (Primary) ; Exenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 28 Jun 2023 Status changed from active, no longer recruiting to completed.
- 12 Sep 2022 Status changed from recruiting to active, no longer recruiting.
- 29 Apr 2022 Planned End Date changed from 1 Mar 2023 to 1 Jul 2023.